Inhibition of interleukin-8 release in the human colonic epithelial cell line HT-29 by cannabinoids

European Journal of Pharmacology

Volumn 458, Issue 1-2, 2003, Pages 207-215

  Ihenetu, Kenneth ^a   Molleman, Areles ^a   Parsons, Mike E ^a   Whelan, Clifford J ^a  

^a UNIVERSITY OF HERTFORDSHIRE   (United Kingdom)

Author keywords

Cannabinoid; HT 29 cell; Inflammatory bowel disease; Interleukin 8; TNF (tumour necrosis factor )

Indexed keywords

2 METHYL 3 (1 NAPHTHOYL) 1 PROPYLINDOLE; 2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; 5 (4 CHLORO 3 METHYLPHENYL) 1 (4 METHYLBENZYL) N (1,3,3 TRIMETHYLBICYCLO[2.2.1]HEPTAN 2 YL) 3 PYRAZOLECARBOXAMIDE; AMIDE; ARACHIDONOYL 2 CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; INTERLEUKIN 8; RIMONABANT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CELL LYSATE; CELL SECRETION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENANTIOMER; EPITHELIUM CELL; HUMAN; HUMAN CELL; INTESTINE CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; WESTERN BLOTTING;

ARACHIDONIC ACIDS; BORNANES; CANNABINOIDS; CELL SURVIVAL; CYCLOHEXANOLS; DOSE-RESPONSE RELATIONSHIP, DRUG; HT29 CELLS; HUMANS; IMMUNOBLOTTING; INDOLES; INTERLEUKIN-8; KINETICS; MORPHOLINES; NAPHTHALENES; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037219120     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(02)02698-5     Document Type: Article

References (40)

1. Baggiolini M., Dewald B., Moser B. Human chemokines: an update. Annu. Rev. Immunol. 15:1997;675-705.
2. Baydoun A.R., Morgan D.M.L. Inhibition of ornithine decarboxylase potentiates nitric oxide production in LPS-activated J774 cells. Br. J. Pharmacol. 125:1998;1511-1516.
3. Berdyshev E.V. Cannabinoid receptors and regulation of immune response. Chem. Phys. Lipids. 108:2000;169-190.
4. Bouaboula M., Rinaldi M., Carayon P., Carillon C., Delpech B., Shire D., Le Fur G., Casellas P. Cannabinoid receptor expression in human leukocytes. Eur. J. Biochem. 214:1993;173-180.
5. Brooks A.C., Gustafsson F., Whelan C.J., Molleman A. Reactive oxygen species generation by non-immunological mast cell activation: modulation by synthetic cannabinoid CP55,940. Br. J. Pharmacol. 128:1999;. (16P).
6. 2, peripheral cannabinoid receptor. J. Pharmacol. Exp. Ther. 291:1999;837-844.
7. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics. 20:1964;482-491.
8. Felder C.C. Cannabinoid receptors and their endogenous agonists. Annu. Rev. Pharmacol. Toxicol. 38:1998;179-200.
9. 2 receptors. Mol. Pharmacol. 48:1995;443-450.
10. Galigue S., Mary S., Marchand J., Dussossoy D., Carriere D., Carayon P., Bouaboula M., Shire D., Le Fur G., Cassellas P. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur. J. Biochem. 232:1995;54-61.
11. Gerard C.M., Mollereau C., Vassart G., Parmentier M. Molecular cloning of a human cannabinoid receptor, which is also expressed in the testes. Biochem. J. 279:1991;129-134.
12. Grimm M.C., Ben-Baruch A., Taub D.D., Howard O.M., Wang J.M., Oppenheim J.J. Opiate inhibition of chemotaxis. Ann. N.Y. Acad. Sci. 840:1998;9-20.
13. Haraguchi S., Good R.A., Day N.K. Immunosuppressive retroviral peptides, cAMP and cytokine patterns. Immunol. Today. 16:1995;595-603.
14. 1). J. Pharmacol. Exp. Ther. 289:1999;1427-1433.
15. Howlett A.C., Fleming R.M. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response of neuroblastoma cell membranes. Mol. Pharmacol. 26:1984;532-538.
16. Ihenetu K., Molleman A., Parsons M.E., Whelan C.J. Modulation of interleukin-8 (IL-8) secretion in human colon epithelial cell line HT-29 by cannabinoids. Br. J. Pharmacol. 134:2001;. (164P).
17. 2 induces MCP-1 and IL-8 gene expression in human promyelocytic cell line HL-60. FEBS Lett. 448:1999;273-277.
18. Jordan N.J., Kolios G., Abbot S.E., Sinai M.A., Thompson D.A., Petraki K., Westwick J. Expression of functional CXCR4 chemokine receptors on human colonic epithelial cells. J. Clin. Invest. 104:1999;1061-1069.
19. Kaminski N.E. Inhibition of the cAMP signalling cascade via cannabinoid receptors: a putative mechanism of immune modulation by cannabinoid compounds. Toxicol. Lett. 102-103:1998;59-63.
20. Kaminski N.E., Abood M.E., Kessler F.K., Martin S.R., Shatz A.R. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid mediated immune modulation. Mol. Pharmacol. 42:1992;736-742.
21. Kenakin T. Methods of drug and receptor classification. Pharmacologic Analysis of Drug-Receptor Interaction. 2nd ed. 1993;344-384 Raven Press, NY.
22. Klein T.W., Kawakami Y., Newton C., Friedman H. Marijuana components suppress induction and cytolytic activity of murine cytolytic T cells in vitro and in vivo. J. Toxicol. Environ. Health. 32:1991;465-477.
23. Luo Y.D., Patel M.K., Wielderhold M.D., Ou D.W. Effects of cannabinoids and cocaine on the mitogen-induced transformations of lymphocytes of human and mouse origins. Int. J. Immunopharmacol. 14:1992;49-56.
24. Mackie K., Hille B. Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells. Proc. Natl. Acad. Sci. U. S. A. 89:1992;3825-3829.
25. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of cloned cDNA. Nature (Lond.). 346:1990;561-564.
26. Matsuda L.A., Bonner T., Lolait S.J. Localisation of cannabinoid receptor mRNA in rat brain. J. Comp. Neurol. 327:1993;535-550.
27. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterisation of peripheral receptor for cannabinoids. Nature (Lond.). 365:1993;61-65.
28. Panja A., Goldberg S., Eckmann L., Mayer L. The regulation and functional consequence of pro-inflammatory cytokine binding on human intestinal epithelial cells. J. Immunol. 161(7):1998;3675-3684.
29. 2 receptors. Pharmacol. Ther. 74:1997;129-180.
30. 2 cannabinoid receptor. FEBBS Lett. 466:2000;300-304.
31. Rinaldi-Carmona M., Barth F., Heaulme M., Shire D., Calandra B., Congy C., Martinez S., Maruani J., Neliat G. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBBS Lett. 350:1994;240-244.
32. 2 cannabinoid receptor. J. Pharmacol. Exp. Ther. 284:1998;644-650.
33. Schuerer-Maly C.-C., Eckmann L., Kagnoff M.F., Falco M.T., Maly F.E. Colonic epithelial cell lines as source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharides. Immunology. 81:1994;85-91.
34. Schwartz H., Blanco F.J., Lotz M. Anandamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J. Neuroimmunol. 55:1994;107-115.
35. Sham R.L., Phatak P.D., Belanger K.A., Packman C.H. The effect of dexamethasone on functional properties of HL60 cells during all trans-retinoic acid-induced differentiation. Are there implications for the retinoic acid syndrome? Blood Cells Mol. Diseases. 22:1996;139-149.
36. Slipetz D.M., O'Neil G.P., Fareu L., Dufresne C., Gallant M., Garen Y., Guoy D., Labelle M., Meltas K.M. Activation of human peripheral cannabinoid receptor results in inhibition of adenyl cyclase. Mol. Pharmacol. 48:1995;352-361.
37. 2, disrupts G-protein coupling. J. Pharmacol. Exp. Ther. 285:1998;651-658.
38. 1 receptors in the rat central nervous system. Neuroscience. 83:1998;393-411.
39. Warhurst A.C., Hopkins S.J., Warhurst G. Interferon gamma induces differential upregulation of α and β chemokine secretion in colonic epithelial cell lines. Gut. 42:1998;208-213.
40. Yang S.K., Eckmann L., Panja A., Kagnoff M.F. Differential and regulated expression of CXC, CC and C chemokine by human colon epithelial cells. Gastroenterology. 113:1997;1214-1223.